Results 131 to 140 of about 6,074,513 (299)

ÐÑоÑеÑÑионалÑÐ½Ð°Ñ Ð¸ ÑизиÑеÑÐºÐ°Ñ Ð¿Ð¾Ð´Ð³Ð¾Ñовка военноÑлÑжаÑÐ¸Ñ Ð¡Ð¨Ð

, 2017
Валерий Александрович Щеголев, Валерий Петрович Сущенко   +1 more
openalex   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

РазÑабоÑка кÑпажиÑованнÑÑ Ñоков ÑÑнкÑионалÑного назнаÑÐµÐ½Ð¸Ñ Ñ Ð¸ÑполÑзованием дикоÑаÑÑÑÑего ÑÑÑÑÑ Ð¡ÐФÐ

, 2017
Екатерина Владимировна Юсифова
openalex   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

ÐÑÑледование возможноÑÑи ÑÑÐ¸Ð»ÐµÐ½Ð¸Ñ ÑоÑоÑока в геÑеÑоÑÑÑÑкÑÑÑÐ°Ñ II - Ñипа на оÑнове ÑзкозоннÑÑ Ð¿Ð¾Ð»ÑпÑоводников Ð3Ð5

, 2017
Андрей Юрьевич Глотов
openalex   +1 more source

Screening for lung cancer: A systematic review of overdiagnosis and its implications

Molecular Oncology, EarlyView.
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz, Laura de la Torre‐Perez, David R Baldwin, Carlijn van der Aalst, Mangesh Thorat, David Ritchie, Andre L Carvalho, Carolina Espina, Ivan Solà, Carlos Canelo‐Aybar, Moira Magdalena Pissinis, Pablo Alonso‐Coello, Ana Carolina Pereira Nunes Pinto   +12 more
wiley   +1 more source

СовеÑÑенÑÑвование меÑодики оÑенки ÑÑÑекÑивноÑÑи деÑÑелÑноÑÑи ÑÑÑеждений кÑлÑÑÑÑÑ Ð² ÑÑеÑе обÑазованиÑ, подведомÑÑвеннÑÑ ÐомиÑеÑÑ Ð¿Ð¾ кÑлÑÑÑÑе СанкÑ-ÐеÑеÑбÑÑга

, 2018
Анастасия Иванова
openalex   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Augmented sets of output differences and new distinguishers for SPN ciphers

Scientific Reports
We introduce augmented vector spaces of output differences, new generic and black-box distinguishers for Substitution Permutation Network (SPN) ciphers.
Rahul Girme, Raghvendra Rohit, Santanu Sarkar   +2 more
doaj   +1 more source

РазÑабоÑка пÑедложений по ÑовеÑÑенÑÑÐ²Ð¾Ð²Ð°Ð½Ð¸Ñ ÑоÑм кÑедиÑÐ¾Ð²Ð°Ð½Ð¸Ñ ÑÑидиÑеÑÐºÐ¸Ñ Ð»Ð¸Ñ (на пÑимеÑе ÐÐР«СбеÑбанк»)

, 2018
Вели Яралиев
openalex   +1 more source